SIGA Technologies Newswire

Comprehensive Real-Time News Feed for SIGA Technologies.

Results 1 - 20 of 38 in SIGA Technologies

  1. PharmAthene, Inc. Reports First Quarter 2015 Financial and Operational ResultsRead the original story

    Thursday May 7 | BioSpace

    Highlights during and subsequent to the quarter include: Implementation of Realignment Plan to maximize the value of any proceeds from its litigation with SIGA Technologies, Inc. and its existing biodefense assets for the corresponding period in 2014. The increase was primarily due to revenue recognition of a one-time payment of represented the difference between actual rates and the provisional rates used to calculate previously billed and recognized revenue.

    Comment?

  2. PharmAthene Reports First Quarter 2015 Financial and Operational ResultsRead the original story

    Thursday May 7 | Freshnews

    ... -- Implementation of Realignment Plan to maximize the value of any proceeds from its litigation with SIGA Technologies, Inc. and its existing biodefense assets -- Recorded revenue of $5.8 million related to the BARDA audit For the three months ended ...

    Comment?

  3. How legally binding is a letter of intent?Read the original story w/Photo

    Apr 23, 2015 | Investopedia

    ... ed recover of "benefit of the bargain" damages between two companies in a mergers and acquisitions deal in SIGA Technologies, Inc v. PharmAthene, Inc.

    Comment?

  4. PharmAthene, Inc. Receives $5.8 Million Payment FromRead the original story

    Apr 12, 2015 | BioSpace

    ... Commission. On Court of Chancery issued its Final Order and Judgment in PharmAthene's litigation against SIGA Technologies, Inc. The Court of Chancery awarded to PharmAthene lump sum expectation damages for the value of PharmAthene's lost profits ...

    Comment?

  5. Smallpox - Pipeline Review, H1 2015: New research report available at Fast Market ResearchRead the original story

    Mar 22, 2015 | PR-inside.com

    ... EpiVax, Inc., Inovio Pharmaceuticals, Inc., MacroGenics, Inc., Nanotherapeutics, Inc., Oncovir, Inc., SIGA Technologies, Inc., Symphogen A/S, TapImmune Inc., Tonix Pharmaceuticals Holding Corp. About Global Markets Direct Global Markets Direct is a ...

    Comment?

  6. SIGA Technologies, Inc. Receives NASDAQ Delisting NotificationRead the original story

    Mar 18, 2015 | BioSpace

    SIGA Technologies, Inc. , a company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, announced that it received a letter today from the Hearings Advisor for The NASDAQ Stock Market LLC , indicating that the NASDAQ Hearings Panel has determined to delist the shares of the Company from the NASDAQ Stock Market and accordingly, suspend trading in the Company's shares effective at the open of business on March 20, 2015. SIGA expects its shares to continue to trade on the OTC Markets under the "SIGAQ" symbol.

    Comment?

  7. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Mar 18, 2015 | Business Wire

    )--SIGA Technologies, Inc. ("SIGA"), a company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, announced t... )--"The Economic Contribution of University/Nonprofit Inventions in the ...

    Comment?

  8. SIGA Technologies Receives NASDAQ Delisting NotificationRead the original story

    Mar 18, 2015 | Freshnews

    SIGA Technologies, Inc. , a company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, announced that it received a letter today from the Hearings Advisor for The NASDAQ Stock Market LLC , indicating that the NASDAQ Hearings Panel has determined to delist the shares of the Company from the NASDAQ Stock Market and accordingly, suspend trading in the Company's shares effective at the open of business on March 20, 2015. SIGA expects its shares to continue to trade on the OTC Markets under the "SIGAQ" symbol.

    Comment?

  9. Sarcoidosis Therapeutic Development and Pipeline Market Review H1...Read the original story w/Photo

    Mar 18, 2015 | PRWeb

    ... Infections. Companies discussed in this report include BioApex, s.r.o., China Biologic Products, Inc., SIGA Technologies, Inc. and Takeda Pharmaceutical Company Limited. Complete report with TOC is available @ ...

    Comment?

  10. PharmAthene, Inc. Reports Year-End 2014 Financial And Operational...Read the original story

    Mar 9, 2015 | BioSpace

    PharmAthene, Inc. , a biodefense company developing medical countermeasures against biological and chemical threats, today reported its financial and operational results for the year ended . In addition, the Company announced that its Board of Directors approved a realignment plan to maximize, for its shareholders, the value of any proceeds from its litigation with SIGA Technologies, Inc. and its existing biodefense assets.

    Comment?

  11. PharmAthene Reports Year-End 2014 Financial And Operational Results;...Read the original story

    Mar 9, 2015 | Freshnews

    ... a realignment plan to maximize, for its shareholders, the value of any proceeds from its litigation with SIGA Technologies, Inc. and its existing biodefense assets. For the year ended December 31, 2014, PharmAthene recognized revenue of ...

    Comment?

  12. New market study, "Dengue - Pipeline Review, H1 2015", has been publishedRead the original story

    Mar 6, 2015 | PR-inside.com

    ... Limited, PaxVax, Prosetta Antiviral Inc., RFS Pharma, LLC, Sanofi Pasteur SA, Sarepta Therapeutics, Inc., SIGA Technologies, Inc., SKAU Vaccines ApS, Takeda Pharmaceutical Company Limited, TechnoVax, Inc., Themis Bioscience GmbH, United Therapeutics ...

    Comment?

  13. SIGA Technologies: Uncovering Hidden Value In BankruptcyRead the original story w/Photo

    Feb 11, 2015 | Seeking Alpha

    ... SIGA has tremendous upside as it looks to renew its contract sometime over the next year or two. SIGA Technologies (NASDAQ: SIGA ) is a company that specializes in the development and commercialization of solutions for serious unmet medical needs ...

    Comment?

  14. PharmAthene, Inc. rPA Antigen Formulated With DepoVax...Read the original story

    Feb 1, 2015 | BioSpace

    ... candidates: Court of Chancery issued its Final Order and Judgment in PharmAthene's litigation against SIGA Technologies, Inc. The Court of Chancery awarded to PharmAthene lump sum expectation damages for the value of PharmAthene's lost profits for ...

    Comment?

  15. PharmAthene rPA Antigen Formulated With DepoVax(TM) Demonstrates...Read the original story

    Feb 2, 2015 | Freshnews

    ... the Delaware Court of Chancery issued its Final Order and Judgment in PharmAthene's litigation against SIGA Technologies, Inc. The Court of Chancery awarded to PharmAthene lump sum expectation damages for the value of PharmAthene's lost profits for ...

    Comment?

  16. Just Published: "Hemorrhagic Fever - Pipeline Review, H2 2014"Read the original story

    Jan 25, 2015 | PR-inside.com

    ... Biotec Limited, Peregrine Pharmaceuticals, Inc., Profectus BioSciences, Inc., Sarepta Therapeutics, Inc., SIGA Technologies, Inc., Sihuan

    Comment?

  17. Dengue Therapeutic Pipeline Drugs and Companies Review H1 2015 Report...Read the original story w/Photo

    Jan 23, 2015 | PRWeb

    ... Limited, PaxVax, Prosetta Antiviral Inc., RFS Pharma, LLC, Sanofi Pasteur SA, Sarepta Therapeutics, Inc., SIGA Technologies, Inc., SKAU Vaccines ApS, Takeda Pharmaceutical Company Limited, TechnoVax, Inc., Themis Bioscience GmbH, United Therapeutics ...

    Comment?

  18. The Delaware Chancery Court Awards Lump-Sum Expectation Damages,...Read the original story w/Photo

    Jan 21, 2015 | jdsupra.com

    This Legal Insight updates our Legal Insight dated June 25, 2013, regarding the Delaware Chancery Court case captioned PharmAthene, Inc. v. SIGA Technologies, Inc. , Civ.

    Comment?

  19. SIGA Technologies, Inc. Appeals Judgment Of Delaware Court Of ChanceryRead the original story

    Jan 18, 2015 | BioSpace

    SIGA Technologies, Inc. , a company operating under the protection of the United States Bankruptcy Court for the Southern District of New York and specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, today announced that it has filed a notice of appeal from the judgment of the Delaware Court of Chancery awarding PharmAthene, Inc. expectation damages.

    Comment?

  20. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Jan 16, 2015 | Business Wire

    T... )--Artisan Partners Asset Management Inc. will report its fourth quarter and full-year 2014 financial results on February 2, 2015 at approximately 4:15 p.m. --SIGA Technologies, Inc. today announced that it has filed a notice of appeal from the judgment of the Delaware Court of Chancery awarding PharmAthene, Inc. expectation da... )--DHL Global Forwarding held a ribbon cutting ceremony today in celebration of the completion of its new $35 million facility in Chicago, Illinois.

    Comment?